Share-based Compensation - Summary of the Company's share options activities (Details) ¥ in Thousands |
12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2025
$ / shares
|
Dec. 31, 2025
CNY (¥)
shares
|
Dec. 31, 2024
$ / shares
|
Dec. 31, 2024
CNY (¥)
shares
|
Dec. 31, 2023
$ / shares
|
Dec. 31, 2023
CNY (¥)
shares
|
Dec. 31, 2022
CNY (¥)
$ / shares
shares
|
Dec. 31, 2025
CNY (¥)
shares
|
Dec. 31, 2024
CNY (¥)
shares
|
Dec. 31, 2023
CNY (¥)
shares
|
|
| Weighted Average Grant-date Fair Value | ||||||||||
| Share-based compensation expenses | ¥ | ¥ 74,319 | ¥ 64,017 | ¥ 37,110 | |||||||
| Employee Stock Option | ||||||||||
| Number of Options | ||||||||||
| Outstanding on beginning | shares | 22,466,275 | 14,934,975 | 20,554,900 | |||||||
| Granted | shares | 2,409,800 | 8,517,000 | 2,984,900 | |||||||
| Exercised | shares | (361,212) | (6,994,625) | ||||||||
| Forfeited | shares | (958,250) | (985,700) | (1,610,200) | |||||||
| Outstanding on end | shares | 23,556,613 | 22,466,275 | 14,934,975 | 20,554,900 | ||||||
| Vested and exercisable | shares | 13,982,607 | 10,098,860 | 2,896,945 | |||||||
| Weighted Average Exercise Price | ||||||||||
| Outstanding on beginning | $ 0.2 | $ 0.14 | $ 0.11 | |||||||
| Granted | 0.4 | 0.32 | 0.28 | |||||||
| Exercised | 0.17 | 0.36 | ||||||||
| Forfeited | 0.29 | 0.25 | 0.2 | |||||||
| Outstanding on end | 0.22 | 0.2 | 0.14 | $ 0.11 | ||||||
| Vested and exercisable | 0.14 | 0.11 | 0.1 | |||||||
| Weighted Average Remaining Contractual life | 6 years 8 months 26 days | 7 years 6 months 3 days | 6 years 11 months 12 days | 8 years 1 month 2 days | ||||||
| Weighted Average Remaining Contractual life, Vested and exercisable | 5 years 6 months 29 days | 6 years 1 month 9 days | 6 years 5 months 8 days | |||||||
| Weighted Average Grant-date Fair Value | ||||||||||
| Outstanding on beginning | 1.43 | 0.76 | 0.49 | |||||||
| Granted | 2.18 | 2.65 | 2.14 | |||||||
| Exercised | 1.07 | 0.4 | ||||||||
| Forfeited | 2.25 | 1.84 | 1.29 | |||||||
| Outstanding on end | 1.48 | 1.43 | 0.76 | $ 0.49 | ||||||
| Vested and exercisable | $ 0.82 | $ 0.49 | $ 0.39 | |||||||
| Aggregated intrinsic value | ¥ | $ 283,331 | ¥ 543,708 | ¥ 501,656 | ¥ 271,425 | ||||||
| Unrecognized compensation expense | ¥ | ¥ 80,900 | ¥ 130,600 | ||||||||
| Share-based compensation expenses | ¥ | ¥ 70,200 | ¥ 61,700 | ¥ 27,500 | |||||||
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options forfeited. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of options vested and expected to vest and exercisable. No definition available.
|
| X | ||||||||||
- Details
|